Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-03-15 Purchase | 2022-03-16 08:35 am | PLx Pharma Inc. | PLXP | Giordano Natasha Chief Executive Officer | 4,100 | $3.6529 | $14,977 | 5,186 (Direct) | View |
2022-03-15 Purchase | 2022-03-16 08:33 am | PLx Pharma Inc. | PLXP | O'Connor Rita M Chief Financial Officer | 13,700 | $3.6585 | $50,122 | 26,670 (Direct) | View |
2021-06-14 Purchase | 2021-06-15 4:47 pm | PLx Pharma Inc. | PLXP | Valentino Michael J Executive Chairman | 8,000 | $12.48 | $99,870 | 494,690 (Direct) | View |
2021-03-05 Purchase | 2021-03-09 5:06 pm | PLx Pharma Inc. | PLXP | Valentino Michael J Executive Chairman | 25,000 | $8 | $200,000 | 486,690 (Direct) | View |
2020-12-14 Purchase | 2020-12-15 5:38 pm | PLx Pharma Inc. | PLXP | HADDEN JOHN Director | 1,000 | $5.448 | $5,448 | 3,690 (Direct) | View |
2020-11-25 Purchase | 2020-11-25 4:08 pm | PLx Pharma Inc. | PLXP | HADDEN JOHN Director | 500 | $5.4757 | $2,738 | 2,690 (Direct) | View |
2020-11-18 Purchase | 2020-11-20 7:46 pm | PLx Pharma Inc. | PLXP | Valentino Michael J Executive Chairman | 264,900 | $3.787 | $1,003,176 | 913,080 (Direct) | View |
2020-09-01 Purchase | 2020-09-03 08:49 am | PLx Pharma Inc. | PLXP | O'Connor Rita M Chief Financial Officer | 6,620 | $3.771 | $24,964 | 12,970 (Direct) | View |
2020-08-20 Purchase | 2020-08-24 09:12 am | PLx Pharma Inc. | PLXP | O'Connor Rita M Chief Financial Officer | 6,350 | $3.8986 | $24,756 | 6,350 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2022-02-22 Option Award | 2022-02-24 8:18 pm | N/A 2032-02-22 | PLx Pharma Inc. | PLXP | Valentino Michael J Executive Chairman | 80,000 | $0 | 80,000 (Direct) | View |
2022-02-22 Option Award | 2022-02-24 8:16 pm | N/A 2032-02-22 | PLx Pharma Inc. | PLXP | O'Connor Rita M Chief Financial Officer | 110,000 | $0 | 110,000 (Direct) | View |
2022-02-22 Option Award | 2022-02-24 8:14 pm | N/A 2032-02-22 | PLx Pharma Inc. | PLXP | HADDEN JOHN Director | 20,000 | $0 | 20,000 (Direct) | View |
2022-02-22 Option Award | 2022-02-24 8:13 pm | N/A 2032-02-22 | PLx Pharma Inc. | PLXP | Giordano Natasha Chief Executive Officer | 300,000 | $0 | 300,000 (Direct) | View |
2022-02-22 Option Award | 2022-02-24 8:12 pm | N/A 2032-02-22 | PLx Pharma Inc. | PLXP | Casale Robert Director | 20,000 | $0 | 20,000 (Direct) | View |
2022-02-22 Option Award | 2022-02-24 8:11 pm | N/A 2032-02-22 | PLx Pharma Inc. | PLXP | CALHOUN KIRK K Director | 20,000 | $0 | 20,000 (Direct) | View |
2022-02-22 Option Award | 2022-02-24 8:10 pm | N/A 2032-02-22 | PLx Pharma Inc. | PLXP | Balkema Gary S. Director | 20,000 | $0 | 20,000 (Direct) | View |
2021-08-09 Option Award | 2021-08-11 09:02 am | N/A 2031-08-09 | PLx Pharma Inc. | PLXP | O'Connor Rita M Chief Financial Officer | 100,000 | $0 | 100,000 (Direct) | View |
2021-08-09 Option Award | 2021-08-11 09:01 am | N/A 2031-08-09 | PLx Pharma Inc. | PLXP | Giordano Natasha Chief Executive Officer | 200,000 | $0 | 200,000 (Direct) | View |
Ownership | 2021-03-16 3:44 pm | N/A N/A | PLx Pharma Inc. | PLXP | Level One Partners LLC Hardie Robert D. Hardie Molly G. 10% Owner | 0 | $0 | 3,647,643 (Direct) | View |
2020-11-18 Option Award | 2020-11-20 7:46 pm | N/A 2030-11-18 | PLx Pharma Inc. | PLXP | Valentino Michael J Executive Chairman | 160,000 | $0 | 913,080 (Direct) | View |
2020-11-18 Option Award | 2020-11-20 7:43 pm | N/A 2030-11-18 | PLx Pharma Inc. | PLXP | O'Connor Rita M Chief Financial Officer | 174,000 | $0 | 174,000 (Direct) | View |
2020-11-18 Option Award | 2020-11-20 7:41 pm | N/A 2030-11-18 | PLx Pharma Inc. | PLXP | HADDEN JOHN Director | 40,000 | $0 | 40,000 (Direct) | View |
2020-11-18 Option Award | 2020-11-20 7:39 pm | N/A 2030-11-18 | PLx Pharma Inc. | PLXP | Giordano Natasha Chief Executive Officer | 350,000 | $0 | 350,000 (Direct) | View |
2020-11-18 Option Award | 2020-11-20 7:36 pm | N/A 2030-11-18 | PLx Pharma Inc. | PLXP | Casale Robert Director | 40,000 | $0 | 40,000 (Direct) | View |
2020-11-18 Option Award | 2020-11-20 7:32 pm | N/A 2030-11-18 | PLx Pharma Inc. | PLXP | CALHOUN KIRK K Director | 40,000 | $0 | 40,000 (Direct) | View |
2020-11-18 Option Award | 2020-11-20 7:30 pm | N/A 2030-11-18 | PLx Pharma Inc. | PLXP | Balkema Gary S. Director | 40,000 | $0 | 40,000 (Direct) | View |
2020-03-20 Option Award | 2020-03-24 8:55 pm | N/A 2030-03-20 | PLx Pharma Inc. | PLXP | Valentino Michael J Executive Chairman | 80,000 | $0 | 80,000 (Direct) | View |
2020-03-20 Option Award | 2020-03-24 8:54 pm | N/A 2030-03-20 | PLx Pharma Inc. | PLXP | O'Connor Rita M Chief Financial Officer | 87,000 | $0 | 87,000 (Direct) | View |
2020-03-20 Option Award | 2020-03-24 8:53 pm | N/A 2030-03-20 | PLx Pharma Inc. | PLXP | HADDEN JOHN Director | 20,000 | $0 | 20,000 (Direct) | View |
2020-03-20 Option Award | 2020-03-24 8:52 pm | N/A 2030-03-20 | PLx Pharma Inc. | PLXP | Giordano Natasha Chief Executive Officer | 175,000 | $0 | 175,000 (Direct) | View |
2020-03-20 Option Award | 2020-03-24 8:50 pm | N/A 2030-03-20 | PLx Pharma Inc. | PLXP | Deliargyris Efthymios Chief Medical Officer | 60,000 | $0 | 60,000 (Direct) | View |
2020-03-20 Option Award | 2020-03-24 8:49 pm | N/A 2030-03-20 | PLx Pharma Inc. | PLXP | Casale Robert Director | 20,000 | $0 | 20,000 (Direct) | View |
2020-03-20 Option Award | 2020-03-24 8:47 pm | N/A 2030-03-20 | PLx Pharma Inc. | PLXP | CALHOUN KIRK K Director | 20,000 | $0 | 20,000 (Direct) | View |
2020-03-20 Option Award | 2020-03-24 8:45 pm | N/A 2030-03-20 | PLx Pharma Inc. | PLXP | Balkema Gary S. Director | 20,000 | $0 | 20,000 (Direct) | View |